Methylphenidate-induced improvements of various measures of attention in adults with Attention Deficit Hyperactivity Disorder

By Tucha O.   Mecklinger L.   Laufkötter R.   Klein H. E.   Walitza S.   Lange K. W.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1575-1592

Springer Publishing Company

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Beyond the 'typical' patient: Treating attention-deficit/hyperactivity disorder in preschoolers and adults

By Vaughan Brigette   Wetzel Martin   Kratochvil Christopher  

International Review of Psychiatry, Vol. 20, Iss. 2, 2008-04 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite